Bacteriological Profile and their Drug Sensitivity Profile in Diabetic Foot Ulcer, a Report from a Tertiary Care Center
Published: 2023-03-30
Page: 15-22
Issue: 2023 - Volume 6 [Issue 1]
Ojas Dagade *
Smt. Kashibai Navale General Hospital, Narhe, Pune 411041, India.
Jeevan Shinde
Smt. Kashibai Navale General Hospital, Narhe, Pune 411041, India.
*Author to whom correspondence should be addressed.
Abstract
Aim: This study aims to identify different microorganisms involved inDiabetic foot ulcers (DFU), compare their antibiotic sensitivity, and find the best combination of empirical antibiotics to treat patients.
Study Design: This is a Prospective observational study of patients treated at Tertiary Health Care Centre, Pune.
Type of Study: Prospective and observational hospital-based study.
Period of Study: From February 2021 to January 2022.
Sample Size: Tissue culture samples were collected from 100 patients.
Results: 81 male and 19 female patients participated in this research.
In this study, according to Wagner’s grading system, 6 patients have Grade 1 ulcers, 21 patients have grade 2 ulcers, 48 patients have grade 3 ulcers, 21 patients have grade 4, and 4 patients have grade 5 ulcers.
Out of 100 cases, 62 patients had neuropathic conditions, 18 patients had neuropathic cases combined with sepsis, 11 patients had neuro ischemic conditions, and 9 had neuro ischemia plus sepsis.
In our study, there were 31 (31%) polymicrobial cases, 65 (65%) monomicrobial cases, and 4 (4%) cases in which the culture was sterile.
Gram-negative bacterial growths were present in 59 (59%) cases compared to 41 (41%) cases where Gram-positive bacterial growths were present.
- aureus (26%) was the most common bacteria isolated, followed by E. coli (20%) and Enterococcus spp (15 percent). Extended-spectrumbeta-lactamase (ESBL) producers made up 53% of the Gram-negative bacteria, Methicillin-resistant staphylococcus aureus (MRSA) made up 41%, and Vancomycin-resistant enterococci (VRE). made up 19%.
Discussion: Most of the patients (63%) in this study were over 45 years old This could be due to a higher incidence of comorbidities.
Higher male prevalence is comparable with a study by Harrison and Lederberg. This might be because men engage in more outdoor physical activity than women, especially in hot, humid environments, with poor foot care.
While GPC was more prevalent in Grades 1 and 2, Gram-negative bacilli and mixed infections were common in Grades 3 and 4, suggesting that Gram-negative infections were associated with severity in DFU and some cases needing limb amputation.
Frequent hospitalization, frequent use of broad-spectrum antibiotics, insufficient surgical source reduction, chronic wounds, irrational use of antibiotics, and the transmission of resistance genes via transport methods are possible causes of MDR. Clinicians should use antibiotics judiciously, on time, and in sufficient amounts, and the relevant organizations should periodically monitor drug intake.
Conclusion: This study demonstrated that among the isolates from the DFUs, multidrug-resistant bacteria predominated. Determining the antibiotics for the empirical therapy of diabetic ulcers will be made easier with knowledge of the pattern of antibiotic resistance among the isolates. Thus, the likelihood of subsequent development of antibiotic resistance as well as the indiscriminate use of antibiotics can be reduced.
Keywords: Diabetic foot ulcers, bacteriological profile, the drug sensitivity profile
How to Cite
Downloads
References
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995 2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21:1414 31.
Ghaderian SB, Hayati F, Shayanpour S, Mousavi SS. Diabetes and end-stage renal disease; a review article on new concepts. Journal of Renal Injury Prevention. 2015; 4(2):28.
Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes/Metabolism Research and Reviews. 2004 May; 20(S1):S68-77.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. Jama. 2005 Jan 12;293(2):217-28.
Richard JL, Sotto A, Lavigne JP. New insights in diabetic foot infection. World Journal of Diabetes. 2011 Feb 2;2(2):24.
Bronze MS, Khardori R, editor. Diabetic foot infections treatment and management. Medscape; 2016.
Available:http://emedicine. medscape.com/article/237378-treatment
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132 73.
Caputo GM, Cavanaugh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med. 1994;331: 854–60.
Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. Diabetes Care. 1998;21: 855–9.
Loeffler RD, Ballard A. Plantar fascial spaces of the foot and a proposed surgical approach. Foot Ankle
James GA, Swogger E, Wolcott R, Pulcini Ed, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37 44.
Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetics. In: Diabetes in America, 2nd edn. Rockville, MD: National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health. 1995;409–28.
Fejfarova, V , Jirkovaska A, Skibova J, Petkov V. Pathogen resistance and other risk factors in the frequency of lower limb amputations with the diabetic foot syndrome. Vnitr Lek. 2002;48:302–6.
Senkowsky J, Money MK, Kerstein MD. Lower extremity amputation: open versus closed. Angiology. 1990;41:222–7.
Zubair M, Malik A, Ahmad J. Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India. Biol Med. 2010;2(4):22-34.
Zubair M, Malik A, Ahmad J. Clinico bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in North India. Biol Med. 2010;2:22 34.
Smith RG. Validation of Wagner's classification: a literature review. Ostomy/Wound Management. 2003 Jan 1;49(1):54-62.
Viswanathan V, Snehalatha C, Seena R, Ramachandran A. Early recognition of diabetic neuropathy: evaluation of a simple outpatient procedure using thermal perception. Postgraduate Medical Journal. 2002 Sep 1;78(923):541-2.
Nelson EA, Backhouse MR, Bhogal MS, Wright Hughes A, Lipsky BA, Nixon J, et al. Concordance in diabetic foot ulcer infection. BMJ Open. 2013;3. pii: E002370
Garcia Garrote F, Cercenado E, Bouza E. Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol. 2000;38:2108 11.
Pincus DH. Microbial Identification Using the Biomérieux VITEK® 2 System. Hazelwood, MO, USA: BioMérieux, Inc. Available:https://store.pda.org/tableofcontents/ermm_v2_ch01.pdf
[Last accessed on 2016 Dec 15]
Al Benwan K, Al Mulla A, Rotimi VO. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public Health. 2012;5:1 8.
Abdulrazak A, Bitar ZI, Al Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complications. 2005;19:138 41.
Banashankari G, Rudresh H, Harsha A. Prevalence of gram negative bacteria in diabetic foot a clinico microbiological study. Al Ameen J Med Sci. 2012;5:224 32.
Hefni AA, Ibrahim AM, Attia KM, Moawad MM, El-ramah AF, Shahin MM, et al. Bacteriological study of diabetic foot infection in Egypt. J Arab Soc Med Res. 2013;8:26 3.
Harrison PF, Lederberg J. Antimicrobial resistance: Issues and options. Washington, DC: Forum on Emerging Infection. 1998;8 74.
Kishore S, Upadhyay AD, VP J. Awareness of foot care among patients with diabetes attending a tertiary care hospital. Natl Med J India. 2015;28:122-5.
El TahawyAT. Bacteriology of diabetic foot. Saudi Med J. 2000;21:344 7.
Amini M, Davati A, Piri M. Determination of the resistance pattern of prevalent aerobic bacterial infections of diabetic foot ulcer. Iran J Pathol. 2013;8:21 6.
Ako Nai A, Ikem I, Akinloye O, Aboderin A, Ikem R, Kassim O. Characterization of bacterial isolates from diabetic foot infections in Ile Ife, Southwestern Nigeria. Foot (Edinb). 2006;16:158 64.
Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med. 2005;16:567 70.
Chahine EB. Diabetic foot infections: An update on treatment. US Pharm. 2013;38:23 6.
Shobha K, Ramachandra L, Rao G, Majumder S, Rao S. Extended spectrum beta lactamases (ESBL) in gram negative bacilli at a tertiary care hospital. J Clin Diagn Res. 2009;3:1307 12.
JaponiA, Vazin A, Hamedi M, Davarpanah MA, Alborzi A, Rafaatpour N. Multidrug resistant bacteria isolated from intensive care unit patient samples. Braz J Infect Dis. 2009;13:118 22.
Akhi MT, Ghotaslou R, Asgharzadeh M, Varshochi M, Pirzadeh T, Memar MY, et al. Bacterial etiology and antibiotic susceptibility pattern of diabetic foot infections in Tabriz, Iran. GMS Hyg Infect ControL. 2015;10:Doc02.
Farshad S, Anvarinejad M, Tavana AM, Ranjbar R, Japoni A, I Zadegan RM, et al. Molecular epidemiology of Escherichia coli strains isolated from patients with diabetic foot ulcers.
Perim MC, Borges Jda C, Celeste SR, Orsolin Ede F, Mendes RR, Mendes GO, et al. Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections. Rev Soc Bras Med Trop. 2015;48:546 54.